Obagi Medical NU-GEN Cellular Renewal Serum

Obagi Medical has launched the NU-GEN Cellular Renewal Serum in the UK. The serum is built around NAD+, a cellular coenzyme that drives energy production and repair in every living cell. NAD+ levels decline naturally with age, slowing cellular efficiency and skin renewal. The formula delivers NAD+ through the proprietary AGE CTRL Complex, a three-part system combining highly soluble NAD+ for rapid energy support alongside its direct precursors NMN and Niacinamide. Together the three actives work to replenish NAD+ levels within skin cells over time, targeting what the brand identifies as a root cause of visible skin ageing rather than its surface symptoms.

Clinical testing across three studies showed visible improvements across nine hallmarks of skin ageing, including uneven skin tone, sagging, fine lines and wrinkles, barrier strength, hydration levels and visible redness. In ageing skin trials over 12 weeks, 95% of participants agreed skin looked brighter and more radiant, with 83% seeing a reduction in the appearance of fine lines and wrinkle depth. In blemish-prone skin trials, 90% noticed improvement within a week, with 88% agreeing skin appeared less red after four weeks. The formula is also clinically proven to provide up to 48 hours of moisturisation. Applied as the first step after cleansing and toning, it is designed for both morning and evening use across all skin types.

Founded in 1988, Obagi Medical is distributed across 47 countries and is the number one leading US physician-recommended medical-grade skincare brand. The NU-GEN Cellular Renewal Serum represents the brand's most significant move into skin longevity science to date.